Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial-Reference-Cited by-同舟云学术

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial

Published:2008-06 Issue:9629 Volume:371 Page:1999-2012
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wood DA,Kotseva K,Connolly S,Jennings C,Mead A,Jones J,Holden A,De Bacquer D,Collier T,De Backer G,Faergeman O

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project;Conroy;Eur Heart J,2003

2. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results;Eur Heart J,1997

3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Euro Heart Survey Programme;Eur Heart J,2001

4. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries;Lancet,2001

Cited by 506 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular Quality Improvement Strategy in India: The C-QIP Trial;American Heart Journal;2024-10

2. ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic—a randomized controlled trial;Cardiovascular Diabetology;2024-07-08

3. The Nurses' Role in the Cardiac Rehabilitation Team;Journal of Cardiovascular Nursing;2024-06-25

4. Long-term risk factor management and adverse events in patients with early-onset myocardial infarction—a “real-world” study;Clinical Research in Cardiology;2024-06-19

5. Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics;Current Pharmaceutical Design;2024-06